A call for an integrated biology – The Lancet

Related Articles:

• ISRIB: The ISR InhiBitor April 24, 2021 # # # # In December 2020, a research paper was published that drew a lot of attention. It involved a molecule that reversed memory deficits in aged mice – even weeks after treatment has stopped. The treatment involved inhibition of the integrated stress response. In today’s post, we will explore what the integrated stress response is, review the data…
• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• The “What would I do” post? Part 2 January 22, 2022 # # # # I am very regularly asked “what would you do if you were diagnosed with Parkinson’s tomorrow?” As a research scientist I don’t really feel comfortable answering it, but I can see how it is a fair question. I have previously attempted to address it (Click here to read that post), and I point folks who do…
• Fall Detection with the Apple Watch September 20, 2019 During the recent Apple product update announcements, something caught my eye and might be of interest to others with Parkinson's – Fall Detection. This watch can now detect if you have fallen and, in reaction, call 911 and an emergency contact if needed. Here is how it works...
• Natural (born) killers January 28, 2020   Today’s post starts with more of a biology lesson than usual, but it is important to understand where in the grand scheme of things a certain type of blood cell sits. That type of blood cell has a really cool name: Natural killer cells. Recently researchers at the University of Georgia (USA) published a report suggesting that natural killer…
• T-cells: First responders November 4, 2020 # # # # The cause of the cell loss and pathology associated with Parkinson’s is still unknown. While the later stages of the condition have been well investigated based on various pathological marker (ie Braak staging), the early manifestations of the condition are still a mystery. Cells of the immune system are early responders to any signs of trouble…
• A nod to immunomod with fingolimod October 16, 2022 # # # # In general, your immune system does a truly amazing job of keeping you healthy and the dangerous pathogenic world around us at bay. Trillions of cells constantly monitoring for viruses and other illness-causing agents, and ruthlessly disposing of any that they actually find. But sometimes your immune system can get a little carried away with this…
• Call for increased research into drug targets for neurodegenerative conditions February 2, 2023 Is there a need for increased research around potential drug targets in Parkinson’s? Find out about a call initiated for large-scale analysis of Omics data to identify potential treatment avenues for neurodegenerative conditions Neurodegenerative conditions, characterised by the death or damage of nervous system cells, affect millions of people around the globe. Parkinson’s and Alzheimer’s are common examples of these…
• Unmasking LRRK2 and GBA May 22, 2021 # # # # Connecting genetics and biology is complicated. Researchers around the world have struggled to determine what each functional region of DNA is doing individually, let alone in combination with other regions. And sometimes when the output of combinations is examined, the results can be unexpected. Recently, researchers looked at the consequences of having a particular combination of…
• A holistic and integrated approach to Parkinson’s care April 26, 2023 Over the coming months, we will be sharing highlights from research supported by the Parkinson Canada Research Program. In this first installment, you’ll hear from Dr. Sarah Lidstone whose specialist training was funded by our Clinical Movement Disorder Fellowship. This is one of the only publicly available funding opportunities that allows doctors to pursue specialized training in the field of…
• Persistent Psychiatric and Neurological Sequalae Observed at 6 Months After COVID-19 Infection April 12, 2021 Substantial psychiatric and neurological morbidities persisted among many for 6 months following a SARS-CoV-2 infection, especially among those who were severely ill. These findings, from a retrospective cohort study, were published in Lancet Psychiatry. Researchers from University of Oxford analyzed data from The TriNetX Analytics Network which included electronic health records from 81 million patients, primarily collected in the United…
• Would the real James Parkinson please stand up December 10, 2022 # # # # In today’s post, we will discuss a common mistake that is made in presentations about Parkinson’s disease.  # # # # I was recently listening to a public lecture on the topic of Parkinson’s, and the presenter (who shall remain nameless) started with a slide that showed this image: And they began with the grand proclamation…
• Fan Fiction: The Joke Machine February 19, 2021 Parking Suns reader David Schneider contributed this amusing-but-still-kinda-scary short story about a man dealing with Parkinson’s on a typical day. Thank you, David! The Joke Machine – – David Schneider Once a friend had come for a weekend visit and ended up staying for two years. The “guest” paid half the rent and slept with a single blanket on the…
• That time APOE met Alpha Syn February 10, 2020    Recently two independent research groups published scientific papers providing evidence that a genetic variation associated with Alzheimer’s may also be affecting the severity of pathology in Parkinson’s. The genetic variation associated with Alzheimer’s occurs in a gene (a functional region of DNA) called ApoE, and the Parkinson’s pathology involves the clustering of a protein called alpha synuclein. Specifically, both…
• Monthly Research Review – May 2022 May 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during May 2022. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Forget Special K, maybe focus on LysoK February 20, 2021 # # # # Over the last 20 years, researchers have identified a number of genetic variations that can confer an increased risk of developing Parkinson’s. Tiny alterations in regions of DNA (called genes) – which provide the instructions for making a protein – can increase one’s chances of Parkinson’s. A better understanding of the biological pathways associated with these…
• The Bluerockers have started July 15, 2021 # # # # On the 8th June, BlueRock Therapeutics put out a press release announcing that the first participant in their Phase I clinical trial of cell transplantation for Parkinson’s had been dosed (Click here to read the press release). The initiation of this clinical trial by the company is a major step forward for them and for the…
• Good News About Bad Seeds May 19, 2023 There has been a lot of talk recently about “seeds” and “seeding assays” in Parkinson disease. What does this mean, and how important are seeds in PD?Much of the interest in seeds has been driven by the recent publication from the Michael J. Fox Foundation Parkinson Progression Marker Initiative (PPMI) study. This is an effort that has been going on…
• AC Immune acquires assets of AFFiRiS July 30, 2021 # # # # Alpha synuclein is considered to be an influential factor in Parkinson’s. It is a protein that accumulates and clumps together inside certain nerve cells in many cases of Parkinson’s. Recently, clinical trials have attempted to target alpha synuclein that is floating around outside of cells. Some of the strategies focus on an approach called ‘immunotherapy’, which…
• Animals in Parkinson's research October 22, 2022 Saturday 22 October 2022  Continuing with the theme of animal models, here is an essay I wrote as part of my MSc neuroscience about the use of animals in Parkinson’s research. Many people, myself included, feel uncomfortable about the use of animals in brain research, an issue for which there are no easy answers. There is quite a bit of…
• Investigating Users' and Other Stakeholders' Needs in the Development of a Personalized Integrated Care Platform (PROCare4Life) for Older People with Dementia or Parkinson Disease: Protocol for a Mixed Methods Study. January 13, 2021 Related ArticlesInvestigating Users' and Other Stakeholders' Needs in the Development of a Personalized Integrated Care Platform (PROCare4Life) for Older People with Dementia or Parkinson Disease: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2021 Jan 12;10(1):e22463 Authors: Ahmed M, Marín M, Bouça-Machado R, How D, Judica E, Tropea P, Bentlage E, Brach M Abstract BACKGROUND: Dementias-including Alzheimer disease-and Parkinson…